Evidence map›Paper›PMID 41867472›Full record

ArticlePractical laboratory medicine2026

A complete blood count-based machine learning model for rapid differentiation of aplastic anemia, immune thrombocytopenia, and myelodysplastic syndromes in routine clinical practice.

Xiaohan Wang, Jian Huang, Jingwen Xi, Huan Liu, Yu Yuan

Abstract read
In one paragraph

Article in Practical laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaohan WangThe Second School of Clinical Medicine, Guangdong Medical University, Dongguan, China.
Jian HuangThe Second School of Clinical Medicine, Guangdong Medical University, Dongguan, China.
Jingwen XiState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Huan LiuGuangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, the School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.
Yu YuanThe Sixth Affiliated Hospital of Guangdong Pharmaceutical University, Dongguan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate differentiation of common hematologic disorders remains challenging in routine clinical practice and often requires invasive diagnostic procedures. Although complete blood count (CBC) testing is widely available, its diagnostic value for early disease triage has not been fully understood. Methods: Retrospectively, among 165,181 routine blood test records collected between October 2011 and June 2025, 4056 samples with confirmed diagnoses were included for model development and validation after exclusion of cases lacking definitive diagnostic information. Patients were classified into aplastic anemia (AA), immune thrombocytopenia (ITP), myelodysplastic syndrome (MDS), and other hematologic conditions. Machine learning models were developed using routinely available CBC parameters. Model performance was assessed using one-vs-rest receiver operating characteristic (ROC) curves, area under the curve (AUC), and class-specific precision, recall, and F1-scores. Model interpretability was evaluated using Shapley Additive exPlanations (SHAP). Results: Baseline demographic and hematologic parameters differed significantly among diagnostic groups (all Conclusions: A machine learning model based on routinely available CBC parameters can support non-invasive differentiation of common hematologic disorders. This approach may serve as a practical screening and triage tool at the outpatient or pre-bone marrow stage, helping optimize the use of invasive diagnostic procedures.

Indexed as

Aplastic anemiaComplete blood countHematologic disordersImmune thrombocytopeniaMachine learningMyelodysplastic syndrome

Identifiers

PMID41867472
PMCPMC12999345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.